A group of Ob-Gyns recently analyzed clinical prognostic factors for survival after recurrence of high-grade, advanced-stage ovarian cancer.
A Cleveland Clinic pilot program aims to end “hospital limbo” for patients by expediting transition from the acute care hospital to an IRF by removing precertification requirements for appropriate patients.
Aspiring to nurse leadership takes self reflection and a plan of action. Cleveland Clinic’s Executive Chief Nursing Officer, K. Kelly Hancock, shares six important tips with nurses who want to move into management.
PET/CT scan shows little evidence of diagnostic utility in the identification of the primary tumor when standard investigations fail.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
A breast oncologist’s take on three new treatment modalities for a difficult-to-treat cancer.
In search for alternatives to insulin replacement, technological solutions, such as the bionic pancreas, may provide safer and more successful treatments.
Ongoing research is pursuing glucocorticoid receptors as a potential therapeutic target to overcome the role of blood-brain barrier dysfunction in pharmacoresistant epilepsy.
Heterogeneity is the rule with bicuspid aortic valves, so optimal surgical solutions vary by patient. Our experts share experience-based guidance for managing various presentations of BAV and aortopathy.
A multicenter study demonstrates the efficacy of dose-adjusted R-EPOCH in treating MYC-translocated DLBCL and double hit DLBCL.
Office-based and surgical treatments for benign prostatic hyperplasia cost the same as just a few years of combination medical therapy, a recent Cleveland Clinic study shows. The results should inform conversations with patients about upfront therapy options.